Date published: 2026-3-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

hnRNP H Inhibitors

hnRNP H inhibitors, also known as heterogeneous nuclear ribonucleoprotein H inhibitors, belong to a class of molecules designed to target and modulate the activity of hnRNP H proteins within the context of cellular processes. hnRNP H proteins are a subset of heterogeneous nuclear ribonucleoproteins, which play a pivotal role in various aspects of RNA metabolism, including pre-mRNA splicing, mRNA transport, and translation regulation. These proteins are essential for the maintenance of RNA structural integrity and the orchestration of gene expression, making them integral components of cellular homeostasis. hnRNP H inhibitors are specifically designed to interfere with the function or expression of hnRNP H proteins, thereby influencing the dynamics of RNA processing and gene regulation.

The development and study of hnRNP H inhibitors have primarily focused on understanding the molecular mechanisms by which these molecules interact with hnRNP H proteins. Researchers have employed a range of techniques, including structural biology, computational modeling, and high-throughput screening, to identify small molecules or compounds that can selectively bind to hnRNP H or disrupt its interactions with RNA substrates. By elucidating the structural and functional aspects of hnRNP H inhibitors, scientists aim to gain insights into the intricate molecular processes underpinning RNA metabolism.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$176.00
$426.00
43
(3)

Doxorubicin may intercalate into DNA, affecting various DNA-associated processes, potentially leading to downregulation of hnRNP H expression as a part of the cellular response to DNA damage.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$37.00
$152.00
11
(1)

As an antimetabolite, Fluorouracil may disrupt RNA processing and synthesis, which could indirectly affect hnRNP H expression by disrupting its mRNA transcription.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

Etoposide causes DNA strand breaks by inhibiting the enzyme topoisomerase II, which could alter transcriptional patterns and possibly downregulate hnRNP H expression.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$138.00
$380.00
101
(4)

Cisplatin forms DNA adducts leading to apoptosis. This process can also affect transcription of certain genes, potentially reducing hnRNP H expression.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D binds to DNA and halts RNA polymerase movement, which can inhibit RNA synthesis and indirectly affect hnRNP H mRNA expression.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide inhibits protein synthesis by interfering with the translocation step in protein elongation, which could result in reduced hnRNP H levels due to a general decrease in protein synthesis.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

Methotrexate inhibits dihydrofolate reductase, leading to a decrease in nucleotide synthesis. This reduction could affect the transcription and expression of hnRNP H.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

Camptothecin inhibits topoisomerase I, preventing DNA from uncoiling and thereby potentially reducing transcription of hnRNP H.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Mithramycin A binds to DNA and inhibits RNA synthesis by preventing the binding of transcription factors, possibly affecting hnRNP H expression levels.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A is a histone deacetylase inhibitor that can alter chromatin structure and gene expression, potentially leading to the downregulation of hnRNP H.